3.3822
price down icon11.97%   -0.4178
 
loading
Schlusskurs vom Vortag:
$3.80
Offen:
$3.72
24-Stunden-Volumen:
652.85K
Relative Volume:
1.37
Marktkapitalisierung:
$34.46M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.51
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
-18.81%
1M Leistung:
-43.78%
6M Leistung:
+52.74%
1J Leistung:
+34.34%
1-Tages-Spanne:
Value
$3.06
$3.80
1-Wochen-Bereich:
Value
$3.06
$4.2284
52-Wochen-Spanne:
Value
$1.50
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Firmenname
iBio Inc
Name
Telefon
302-355-0650
Name
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
IBIO's Discussions on Twitter

Vergleichen Sie IBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBIO
iBio Inc
3.345 34.46M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
480.81 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.50 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
559.07 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
244.92 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
239.78 26.46B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-28 Eingeleitet Chardan Capital Markets Buy
2021-11-29 Eingeleitet JMP Securities Mkt Outperform
2021-01-22 Eingeleitet Cantor Fitzgerald Overweight
2020-06-26 Eingeleitet Alliance Global Partners Buy

iBio Inc Aktie (IBIO) Neueste Nachrichten

pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025
pulisher
Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Feb 19, 2025
pulisher
Feb 19, 2025

iBio Announces Transfer to Nasdaq Capital Market - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey

Feb 17, 2025
pulisher
Feb 17, 2025

10 Stocks Insiders Are Buying This Year - Insider Monkey

Feb 17, 2025
pulisher
Feb 12, 2025

Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks

Feb 12, 2025
pulisher
Feb 11, 2025

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Feb 11, 2025
pulisher
Feb 11, 2025

SEC Form 424B3 filed by iBio Inc. - Quantisnow

Feb 11, 2025
pulisher
Feb 10, 2025

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Inc. (IBIO) reports earnings - Quartz

Feb 10, 2025
pulisher
Feb 10, 2025

iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan

Feb 10, 2025
pulisher
Feb 07, 2025

A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World

Feb 07, 2025
pulisher
Feb 04, 2025

iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World

Feb 04, 2025
pulisher
Feb 04, 2025

iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World

Feb 04, 2025

Finanzdaten der iBio Inc-Aktie (IBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Kapitalisierung:     |  Volumen (24h):